CClinicalTrials.gg
CompletedNCT02692612Updated May 19, 2022

Effects of Power-velocity Muscle Characteristics During Ageing

An observational study in Sarcopenia, sponsored by Universitaire Ziekenhuizen KU Leuven. Completed at 1 site in Belgium. Open to participants aged 20 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-19.

Sponsored by Universitaire Ziekenhuizen KU Leuven · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
98
Ages
20 Years to 80 Years
Sex
All
01

Study summary

The purpose of this project is to investigate the age-related differences in force-velocity muscle characteristics during isolated knee extensions variable in speed and load, during cyclic movements on a usual and recumbent bike variable in speed and velocity development and a functional test battery with healthy participants aged between 20-80 years.

02

Conditions studied

  • Sarcopenia

Browse trials for

03

In context

Sarcopenia

1,208 studies on the registry are indexed under Sarcopenia; 402 are open to participants now.

This study's enrollment of 98 is below the median of 120 across 419 observational studies indexed under Sarcopenia.

Browse Sarcopenia studies →

Lead sponsor

Universitaire Ziekenhuizen KU Leuven is the lead sponsor of 928 studies on the registry; 261 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

young (20-40y) middle-aged (40-60y) old (60-80y)

Inclusion criteria

  • healthy volunteers age 20 to 80 years

Exclusion criteria

Exclusion Criteria:

  • Knee or hip prothesis
  • Systematic training
  • Cardiovascular disease
  • Acute lower back pain
  • Acute knee pain
  • Dementia
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
98 participants (actual)
Patient registry
No

Groups and cohorts

  • Young
  • Middle-Aged
  • Old
06

What researchers measure

Primary outcomes

  1. Differences in power-velocity characteristics during ageing

    peak power and rate of power development (slope) at different velocities during knee extension movement and cyclic multijoint leg press movement compared between young and old people

    Time frame: 1x at baseline (cross sectional study)

Secondary outcomes

  1. Reliability of strength tests on regular and recumbent bike.

    reliability of peak power and rate of power development outcomes measured twice within a period of 2 weeks

    Time frame: 1x at baseline (cross sectional study)

  2. Differences in muscle fascicle characteristics during ageing.

    Differences between young and old people of fascicle shortening velocity during dynamic leg press movements measured via dynamic ultrasound

    Time frame: 1x at baseline (cross sectional study)

  3. Differences in muscle activation during ageing.

    Differences in muscle activation pattern during dynamic leg press movements measured via muscle electromyography

    Time frame: 1x at baseline (cross sectional study)

07

Study locations

1 site
  • Faculty of kinesiology and rehabilitation sciences
    Leuven, 3000, Belgium
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 19, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02692612
Lead sponsor
Universitaire Ziekenhuizen KU Leuven
Responsible party
Sponsor
First posted
Feb 26, 2016
Start date
Feb 2016
Primary completion
Jul 2016
Completion
Jul 2016
Last update
May 19, 2022
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion